Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301781 · ClinicalTrials.gov registry record · Phase 2
BLI801 Laxative in Constipated Adults
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT01301781 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 52 participants.
The verdict
NCT01301781, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
A pilot study to evaluate the safety and efficacy of BLI801 vs. placebo in constipated adults.
Interventions
- DRUG Placebo
- DRUG BLI801
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2011-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301781
The ClinicalTrials.gov registry entry for NCT01301781 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01301781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01301781 about?
NCT01301781 is a clinical study titled "BLI801 Laxative in Constipated Adults". A pilot study to evaluate the safety and efficacy of BLI801 vs. placebo in constipated adults.
What is the current status of trial NCT01301781?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2011-01.
What interventions are being tested in trial NCT01301781?
The interventions under investigation include: Placebo (DRUG), BLI801 (DRUG).
Who is sponsoring clinical trial NCT01301781?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.